Clinical Trial Participant Retention Email Sequence Specification

Role: Senior Director of Patient Engagement and Clinical Trial Retention.

Context

• Protocol identifier and phase: {{protocol_name}}
• Therapeutic focus area: {{therapeutic_indication}}
• Patient cohort characteristics: {{participant_cohort_demographics}}
• High-attrition study interval: {{attrition_risk_milestone}}
• Digital participant interface: {{econsent_portal_url}}
• Ethical review and consent boundaries: {{irb_compliance_parameters}}

Task

Produce an IRB-ready email lifecycle journey specification that guides enrolled clinical trial participants through {{attrition_risk_milestone}}, reducing drop-off rates and reinforcing visit compliance for {{protocol_name}}.

Method

1. Map participant emotional and logistical burden during {{attrition_risk_milestone}} based on {{therapeutic_indication}} patient journeys.
2. Define a multi-touch email cadence tailored to {{participant_cohort_demographics}} cognitive load and communication preferences.
3. Draft email copy blueprints using plain language (Flesch-Kincaid Grade 6-8) adhering to {{irb_compliance_parameters}}.
4. Design visit preparation modules that clearly outline site visit requirements, fasting rules, or home biosensor tasks.
5. Integrate interactive prompts directing patients seamlessly to {{econsent_portal_url}} for e-diary submissions.
6. Establish safety reporting callouts and 24/7 site coordinator escalation triggers within every email template.
7. Detail behavioral retention hooks that validate participant contribution to science without offering undue inducement.

Constraints

• Messaging MUST strictly comply with GCP guidelines and {{irb_compliance_parameters}}.
• Content MUST NOT promise therapeutic benefit or curative outcomes from the investigational product.
• Language must be accessible to lay readers, avoiding dense clinical jargon.
• Total email touchpoints in the spec must be bounded between 3 and 5 distinct emails.

Output format

Provide a comprehensive specification organized as:

1. Email Sequence Architecture & Trigger Logic (Table: Phase, Trigger, Timing, Goal)
2. Individual Email Specifications (For each email: Purpose, Plain Language Subject Line, Header, Modular Body Copy, Direct Action Trigger, Emergency Escalation Footer)
3. Participant Accessibility & Reading Level Verification (Metrics summary)
4. Regulatory & IRB Submission Notes (Summary of guardrails applied)

Self-review

• Ensure no coercive incentives or unapproved clinical claims exist in any message draft.
• Verify all links to {{econsent_portal_url}} are contextualized with clear privacy reminders.
• Confirm the sequence directly mitigates known friction points of {{attrition_risk_milestone}}.